U.S. International Development Finance Corporation (DFC) Current Affairs, GK & News

CORBEVAX’ gets DCGI approval for Clinical trials

The Drug Controller General of India (DCGI) gave approval to another indigenous COVID-19 vaccine candidate called CORBEVAX for two clinical trials. Highlights Vaccine maker Biological E received approval to conduct phase two and three clinical trials on children between five to eighteen years of age. Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council ..